Exact Mass: 960.4150154

Exact Mass Matches: 960.4150154

Found 16 metabolites which its exact mass value is equals to given mass value 960.4150154, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

PIP(16:0/5-iso PGF2VI)

{[(1S,6R,10Z,13R,14S,16R,17S,18R,19R,20R,21S,22R)-6-[(hexadecanoyloxy)methyl]-3,14,16,18,20,21,22-heptahydroxy-17-[(1E,3R)-3-hydroxyoct-1-en-1-yl]-3,8-dioxo-2,4,7-trioxa-3lambda5-phosphabicyclo[11.6.3]docos-10-en-19-yl]oxy}phosphonic acid

C43H78O19P2 (960.4612298000001)


PIP(16:0/5-iso PGF2VI) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(16:0/5-iso PGF2VI), in particular, consists of one chain of hexadecanoyl at the C-1 position and one chain of 5-iso Prostaglandin F2alpha-VI at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(5-iso PGF2VI/16:0)

{[(1S,6R,11Z,14R,15S,17R,18S,19R,20R,21R,22S,23R)-6-(hexadecanoyloxy)-3,15,17,19,21,22,23-heptahydroxy-18-[(1E,3R)-3-hydroxyoct-1-en-1-yl]-3,9-dioxo-2,4,8-trioxa-3lambda5-phosphabicyclo[12.6.3]tricos-11-en-20-yl]oxy}phosphonic acid

C43H78O19P2 (960.4612298000001)


PIP(5-iso PGF2VI/16:0) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(5-iso PGF2VI/16:0), in particular, consists of one chain of 5-iso Prostaglandin F2alpha-VI at the C-1 position and one chain of hexadecanoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   
   
   
   
   
   
   
   
   
   
   

Autoinducing Peptide I

Autoinducing Peptide I

C43H60N8O13S2 (960.372107)


Autoinducing Peptide I is a cyclic octapeptide secreted by Staphylococcus aureus and can be used in vaccine research[1].

   

methyl (4s,5e,6s)-5-ethylidene-4-(2-{[(1s,2r,3s,5s)-3-({2-[(2s,3e,4s)-3-ethylidene-5-(methoxycarbonyl)-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,4-dihydropyran-4-yl]acetyl}oxy)-5-[(2s)-1-hydroxypropan-2-yl]-2-methylcyclopentyl]methoxy}-2-oxoethyl)-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,6-dihydropyran-3-carboxylate

methyl (4s,5e,6s)-5-ethylidene-4-(2-{[(1s,2r,3s,5s)-3-({2-[(2s,3e,4s)-3-ethylidene-5-(methoxycarbonyl)-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,4-dihydropyran-4-yl]acetyl}oxy)-5-[(2s)-1-hydroxypropan-2-yl]-2-methylcyclopentyl]methoxy}-2-oxoethyl)-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,6-dihydropyran-3-carboxylate

C44H64O23 (960.3838194)


   

[(3s,6s,9s,12s,15r)-15-{[(2s,3r)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1,3-dihydroxypropylidene]amino}-1,3-dihydroxybutylidene]amino}-9-benzyl-6-[(2s)-butan-2-yl]-5,8,11,14-tetrahydroxy-3-[2-(methylsulfanyl)ethyl]-2-oxo-1-thia-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-12-yl]acetic acid

[(3s,6s,9s,12s,15r)-15-{[(2s,3r)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1,3-dihydroxypropylidene]amino}-1,3-dihydroxybutylidene]amino}-9-benzyl-6-[(2s)-butan-2-yl]-5,8,11,14-tetrahydroxy-3-[2-(methylsulfanyl)ethyl]-2-oxo-1-thia-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-12-yl]acetic acid

C43H60N8O13S2 (960.372107)


   

methyl (4s,5e,6s)-5-ethylidene-4-{2-[(2r)-2-[(1s,2r,3r,4s)-4-({2-[(2s,3e,4s)-3-ethylidene-5-(methoxycarbonyl)-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,4-dihydropyran-4-yl]acetyl}oxy)-2-(hydroxymethyl)-3-methylcyclopentyl]propoxy]-2-oxoethyl}-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,6-dihydropyran-3-carboxylate

methyl (4s,5e,6s)-5-ethylidene-4-{2-[(2r)-2-[(1s,2r,3r,4s)-4-({2-[(2s,3e,4s)-3-ethylidene-5-(methoxycarbonyl)-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,4-dihydropyran-4-yl]acetyl}oxy)-2-(hydroxymethyl)-3-methylcyclopentyl]propoxy]-2-oxoethyl}-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,6-dihydropyran-3-carboxylate

C44H64O23 (960.3838194)